Pro Speaker

Date 01 October 2012
Event ESMO Congress 2012
Session Can neo-adjuvant breast cancer data be used to accelerate drug approval?
Topics Anticancer agents
Breast Cancer
Therapy
Biological Therapy
Presenter José Baselga
Authors J. Baselga
  • Hematology Oncology, Massachusetts General Hospital, 02114 - Boston/US